<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="293">
  <stage>Registered</stage>
  <submitdate>25/08/2005</submitdate>
  <approvaldate>2/09/2005</approvaldate>
  <actrnumber>ACTRN12605000262606</actrnumber>
  <trial_identification>
    <studytitle>Cumberland Low Back Pain Trial</studytitle>
    <scientifictitle>The effect of motor control exercise versus placebo in patients with chronic low back pain</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Non-specific chronic low back pain</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be randomly assigned to one of 2 groups.  Both groups will attend 12 x 1/2 hour sessions of treatment over an 8 week period.
Group 1 will receive a motor control exercise program designed to restore control of the trunk muscles. </interventions>
    <comparator>Group 2 will receive a placebo treatment of 20 mins of detuned shortwave diathermy and 5 mins of detuned ultrasound.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Average pain intensity over last week (0-10 scale) </outcome>
      <timepoint>Measured at 2 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Global perceived effect (Global Perceived Effect Scale)</outcome>
      <timepoint>Measured at 2 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Patient-generated measure of disability (Patient-Specific Functional Scale)</outcome>
      <timepoint>Measured at 2 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Recurrence</outcome>
      <timepoint>At 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>(i)Average pain intensity over last week (0-10 scale) </outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>(ii) Global perceived effect (Global Perceived Effect Scale)</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>(iii)Patient- generated measure of disability (Patient-Specific Functional Scale)</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>(iv) Condition-specific measure of disability (Roland Morris Disability Questionnaire) </outcome>
      <timepoint>Measured at baseline, 6 months and 12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(i)Non-specific low back pain +/- leg pain of at least 3 months duration (ii)Currently seeking care for low back pain (iii) English speaker (iv)Clinical assessment indicates that the subject is suitable for motor control exercise.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>(i)Suspected or confirmed serious spinal pathology (fracture, metastatic, inflammatory or infective diseases of the spine, cauda equina syndrome/widespread neurological disorder).(ii)Suspected or confirmed pregnancy(iii)Are unable to speak English(iv)Nerve root compromise (2 of strength, reflex or sensation affected for same nerve root)(v)Spinal surgery in the past 12 months.(vi)Scheduled for major surgery during treatment or follow-up period (vii)Any of the contraindications to exercise listed on page 42 of the ACSM guidelines (ACSM's Guidelines for Exercise Testing and Prescription, 1995).(viii)Any contraindication to pulsed ultrasound or pulsed shortwave.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>The allocation sequence will be generated using random number function in Excel, blocking will also be used.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>1/10/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>154</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Sydney</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Leonardo Oliveira Pena Costa</name>
      <address>C/- School of Physiotherapy
Faculty of Health Sciences
University of Sydney
Cumberland Campus
PO Box 170
Lidcombe NSW 1825</address>
      <phone>+61 2 93519682</phone>
      <fax />
      <email>lcos3060@usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Leonardo Oliveira Pena Costa</name>
      <address>C/- School of Physiotherapy
Faculty of Health Sciences
University of Sydney
Cumberland Campus
PO Box 170
Lidcombe NSW 1825</address>
      <phone>+61 2 93519682</phone>
      <fax />
      <email>lcos3060@usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>